NFJ Investment Group LLC Makes New $1.60 Million Investment in Omnicell, Inc. (NASDAQ:OMCL)

NFJ Investment Group LLC bought a new stake in shares of Omnicell, Inc. (NASDAQ:OMCL) during the fourth quarter, Holdings Channel.com reports. The fund bought 35,897 shares of the company’s stock, valued at approximately $1,598,000.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Smartleaf Asset Management LLC boosted its holdings in Omnicell by 51.5% in the 4th quarter. Smartleaf Asset Management LLC now owns 803 shares of the company’s stock worth $35,000 after buying an additional 273 shares during the last quarter. Van ECK Associates Corp boosted its stake in shares of Omnicell by 47.0% in the fourth quarter. Van ECK Associates Corp now owns 985 shares of the company’s stock worth $44,000 after acquiring an additional 315 shares during the last quarter. Headlands Technologies LLC purchased a new stake in shares of Omnicell during the fourth quarter worth approximately $53,000. First Horizon Advisors Inc. raised its stake in Omnicell by 36.3% in the 4th quarter. First Horizon Advisors Inc. now owns 1,333 shares of the company’s stock valued at $59,000 after purchasing an additional 355 shares during the last quarter. Finally, Huntington National Bank lifted its holdings in Omnicell by 236.4% in the 4th quarter. Huntington National Bank now owns 1,359 shares of the company’s stock valued at $61,000 after purchasing an additional 955 shares in the last quarter. Hedge funds and other institutional investors own 97.70% of the company’s stock.

Omnicell Price Performance

OMCL stock opened at $30.28 on Friday. Omnicell, Inc. has a 52-week low of $25.12 and a 52-week high of $55.75. The business has a fifty day moving average of $35.49 and a two-hundred day moving average of $41.36. The stock has a market cap of $1.42 billion, a price-to-earnings ratio of 112.15, a price-to-earnings-growth ratio of 7.53 and a beta of 0.78. The company has a quick ratio of 1.22, a current ratio of 1.37 and a debt-to-equity ratio of 0.13.

Omnicell (NASDAQ:OMCL) last issued its quarterly earnings data on Thursday, February 6th. The company reported $0.45 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.57 by ($0.12). Omnicell had a net margin of 1.13% and a return on equity of 3.82%. As a group, research analysts anticipate that Omnicell, Inc. will post 1.09 earnings per share for the current year.

Analyst Ratings Changes

A number of research firms have recently issued reports on OMCL. Wells Fargo & Company dropped their target price on shares of Omnicell from $40.00 to $38.00 and set an “equal weight” rating for the company in a report on Thursday. Benchmark reissued a “buy” rating and issued a $62.00 target price on shares of Omnicell in a research note on Tuesday, February 4th. JPMorgan Chase & Co. dropped their price target on Omnicell from $44.00 to $36.00 and set a “neutral” rating for the company in a research report on Thursday, March 20th. StockNews.com upgraded Omnicell from a “hold” rating to a “buy” rating in a research report on Tuesday. Finally, Bank of America dropped their target price on Omnicell from $54.00 to $46.00 and set a “neutral” rating for the company in a report on Monday, January 6th. Four equities research analysts have rated the stock with a hold rating and three have given a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Hold” and an average target price of $50.67.

About Omnicell

Omnicell, Inc, together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital, as well as specialized automated dispensing systems for operating room; and robotic dispensing systems for handling the stocking and retrieval of boxed medications.